(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MIMÉTICOS DE HEPCIDINA PARA TRATAMENTO DE HEMOCROMATOSE HEREDITÁRIA

Em AnáliseInvention PatentPCT · US2022033378

Application data

Invention Patent MIMÉTICOS DE HEPCIDINA PARA TRATAMENTO DE HEMOCROMATOSE HEREDITÁRIA de PROTAGONIST THERAPEUTICS, INC. — IPC A61P 7/06
Invention Patent MIMÉTICOS DE HEPCIDINA PARA TRATAMENTO DE HEMOCROMATOSE HEREDITÁRIA de PROTAGONIST THERAPEUTICS, INC. — IPC A61P 7/06. Drawing published by the INPI in the Industrial Property Gazette.

Number

112023026381

Type

Invention Patent

Filing

06/14/2022

Publication

03/05/2024

PCT

US2022033378

Progress at the INPI

  1. Filing06/14/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 06/14/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/05/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PROTAGONIST THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

D. L. (pessoa física)

US

F. V. (pessoa física)

US

N. M. (pessoa física)

US

S. G. (pessoa física)

US

Technical data

Priority claims

US

63/210,453 · 06/14/2021

US

63/252,001 · 10/04/2021

US

63/349,841 · 06/07/2022

Abstract

MIMÉTICOS DE HEPCIDINA PARA TRATAMENTO DE HEMOCROMATOSE HEREDITÁRIA. A divulgação fornece métodos para o tratamento e/ou prevenção de doenças de sobrecarga de ferro, tais como hemocromatose hereditária.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

03/05/2024

RPI 2774

Alteração de dados cadastrais

#1.1

12/26/2023

RPI 2764

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.